Lexaria Bioscience Corp. — Director's Dealing 2015

Jan 30, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2015-01-20

Reporting Person: Bhullar Baljinder (Director, CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-01-01	Stock Options	$0.2	E	300000	Disposed	2015-01-20	Common Shares (300000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	141250	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.35	2016-07-11	Common Shares (100000)	100000	Direct
Stock Options	$0.1	2018-06-18	Common Shares (175000)	275000	Direct
Stock Options	$0.11	2019-12-23	Common Shares (500000)	775000	Direct
Warrants	$0.25	2015-09-21	Common Shares (100000)	100000	Direct